Michael G. Morash

Michael G. Morash


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
Paul S. HoffmanPaul S. Hoffman
Paul S. Hoffman
GSGary Sisson
Gary Sisson
MCMatthew A. Croxen
Matthew A. Croxen
KWKevin Welch
Kevin Welch
WHW. Dean Harman
W. Dean Harman
MMMichael G. Morash
Michael G. Morash
Nitazoxanide (NTZ) exhibits broad-spectrum activity against anaerobic bacteria and parasites and the ulcer-causing pathogen Helicobacter pylori . Here we show that NTZ is a noncompetitive inhibitor ( K i , 2 to 10 μM) of the pyruvate:ferredoxin/flavodoxin oxidoreductases (PFORs) of Trichomonas vaginalis , Entamoeba histolytica , Giardia intestinalis , Clostridium difficile , Clostridium perfringens , H. pylori , and Campylobacter jejuni and is weakly active against the pyruvate dehydrogenase of Escherichia coli . To further mechanistic studies, the PFOR operon of H. pylori was cloned and overexpressed in E. coli , and the multisubunit complex was purified by ion-exchange chromatography. Pyruvate-dependent PFOR activity with NTZ, as measured by a decrease in absorbance at 418 nm (spectral shift from 418 to 351 nm), unlike the reduction of viologen dyes, did not result in the accumulation of products (acetyl coenzyme A and CO 2 ) and pyruvate was not consumed in the reaction. NTZ did not displace the thiamine pyrophosphate (TPP) cofactor of PFOR, and the 351-nm absorbing form of NTZ was inactive. Optical scans and 1 H nuclear magnetic resonance analyses determined that the spectral shift ( A 418 to A 351 ) of NTZ was due to protonation of the anion (NTZ − ) of the 2-amino group of the thiazole ring which could be generated with the pure compound under acidic solutions (pK a = 6.18). We propose that NTZ − intercepts PFOR at an early step in the formation of the lactyl-TPP transition intermediate, resulting in the reversal of pyruvate binding prior to decarboxylation and in coordination with proton transfer to NTZ. Thus, NTZ might be the first example of an antimicrobial that targets the “activated cofactor” of an enzymatic reaction rather than its substrate or catalytic sites, a novel mechanism that may escape mutation-based drug resistance.

3 December 2002 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
NBNeil Burford
Neil Burford
MEMelanie D. Eelman
Melanie D. Eelman
DMDavid E. Mahony
David E. Mahony
MMMichael G. Morash
Michael G. Morash
Solutions containing BiCl3, bismuth subsalicylate or Bi(NO3)3 with L-cysteine, DL-homocysteine, D-methionine or glutathione have been examined by electrospray mass spectrometry. Prominent peaks are assigned to bismuth complexes of these biomolecules and provide insight towards understanding the bioactivity of bismuth compounds.

1 August 2003 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
ABAnn Karen C. Brassinga
Ann Karen C. Brassinga
MHMargot F. Hiltz
Margot F. Hiltz
GSGary R. Sisson
Gary R. Sisson
MMMichael G. Morash
Michael G. Morash
NHNathan Hill
Nathan Hill
PHPaul S. Hoffman
Paul S. Hoffman
Nucleotide sequence analysis of an ∼80-kb genomic region revealed an ∼65-kb locus that bears hallmarks of a pathogenicity island. This locus includes homologues of a type IV secretion system, mobile genetic elements, and known virulence factors. Comparative studies with other Legionella pneumophila strains and serogroups indicated that this ∼65-kb locus is unique to L . pneumophila serogroup 1 Philadelphia-1 strains.

1 September 2011 in Disease Models & Mechanisms
Verified
Journal Article
Open access
MMMichael G. Morash
Michael G. Morash
SDSusan E. Douglas
Susan E. Douglas
ARAnna Robotham
Anna Robotham
CRChristina Marie Ridley
Christina Marie Ridley
JGJeffrey W. Gallant
Jeffrey W. Gallant
KSKelly H. Soanes
Kelly H. Soanes
SUMMARY: The emergence of multidrug-resistant cancers and the lack of targeted therapies for many cancers underscore an unmet need for new therapeutics with novel modes of action towards cancer cells. Host-defense peptides often exhibit selective cytotoxicity towards cancer cells and show potential as anti-cancer therapeutics. Here, we screen 26 naturally occurring variants of the peptide pleurocidin for cytotoxic and anti-cancer activities, and investigate the underlying mechanism of action. Cytotoxicities were assessed in vitro using cell-based assays and in vivo using zebrafish embryos. Morphological changes were assessed by both transmission and scanning electron microscopy, and functional assays were performed on zebrafish embryos to investigate the mechanism of cell death. A total of 14 peptides were virtually inactive against HL60 human leukemia cells, whereas 12 caused >50% death at ≤32 μg/ml. Morphological changes characteristic of oncosis were evident by electron microscopy after only 1 minute of treatment with 32 μg/ml of variant NRC-03. Only two peptides were hemolytic. Four peptides showed no toxicity towards zebrafish embryos at the highest concentration tested (25 μM; ∼64 μg/ml) and one peptide was highly toxic, killing 4-hour-post-fertilization (hpf) embryos immediately after exposure to 1 μM peptide. Four other peptides killed embryos after 24 hours of exposure at 1 μM. Most peptides caused mortality at one or more developmental stages only after continuous exposure (24 hours) with higher lethal doses (≥5 μM). Pleurocidin NRC-03 bound to embryos and induced the release of superoxide, caused an increase in the number of TUNEL-positive nuclei, and caused membrane damage and the loss of embryonic epithelial integrity, marked by the exclusion of cells from the outer epithelium and the appearance of F-actin within the circumferential cells of the repair site. Our results indicate that specific pleurocidin variants are attractive cancer-selective agents that selectively induce cell death in target cells but leave non-target cells such as erythrocytes and non-transformed cells unaffected.

1 April 2009 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
MMMichael G. Morash
Michael G. Morash
ABAnn Karen C. Brassinga
Ann Karen C. Brassinga
MWMichelle Warthan
Michelle Warthan
PGPoornima Gourabathini
Poornima Gourabathini
RGRafael A. Garduño
Rafael A. Garduño
Paul S. HoffmanPaul S. Hoffman
Paul S. Hoffman
Legionella pneumophila is an intracellular parasite of protozoa that differentiates late in infection into metabolically dormant cysts that are highly infectious. Regulation of this process is poorly understood. Here we report that the small DNA binding regulatory proteins integration host factor (IHF) and HU are reciprocally expressed over the developmental cycle, with HU expressed during exponential phase and IHF expressed postexponentially. To assess the role of these regulatory proteins in development, chromosomal deletions were constructed. Single ( ihfA or ihfB ) and double deletion (Δ ihf ) IHF mutants failed to grow in Acanthamoeba castellanii unless complemented in trans when expressed temporally from the ihfA promoter but not under P tac (isopropyl-β- d -thiogalactopyranoside). In contrast, IHF mutants were infectious for HeLa cells, though electron microscopic examination revealed defects in late-stage cyst morphogenesis (thickened cell wall, intracytoplasmic membranes, and inclusions of poly-β-hydroxybutyrate), and were depressed for the developmental marker MagA. Green fluorescent protein promoter fusion assays indicated that IHF and the stationary-phase sigma factor RpoS were required for full postexponential expression of magA . Finally, defects in cyst morphogenesis noted for Δ ihf mutants in HeLa cells correlated with a loss of both detergent resistance and hyperinfectivity compared with results for wild-type cysts. These studies establish IHF and HU as markers of developmental stages and show that IHF function is required for both differentiation and full virulence of L. pneumophila in natural amoebic hosts.

19 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LELee D. Ellis
Lee D. Ellis
ESEvelyn C. Soo
Evelyn C. Soo
JAJohn Achenbach
John Achenbach
MMMichael G. Morash
Michael G. Morash
KSKelly H. Soanes
Kelly H. Soanes
The smoking of tobacco continues to be the leading cause of premature death worldwide and is linked to the development of a number of serious illnesses including heart disease, respiratory diseases, stroke and cancer. Currently, cell line based toxicity assays are typically used to gain information on the general toxicity of cigarettes and other tobacco products. However, they provide little information regarding the complex disease-related changes that have been linked to smoking. The ethical concerns and high cost associated with mammalian studies have limited their widespread use for in vivo toxicological studies of tobacco. The zebrafish has emerged as a low-cost, high-throughput, in vivo model in the study of toxicology. In this study, smoke condensates from 2 reference cigarettes and 6 Canadian brands of cigarettes with different design features were assessed for acute, developmental, cardiac, and behavioural toxicity (neurotoxicity) in zebrafish larvae. By making use of this multifaceted approach we have developed an in vivo model with which to compare the toxicity profiles of smoke condensates from cigarettes with different design features. This model system may provide insights into the development of smoking related disease and could provide a cost-effective, high-throughput platform for the future evaluation of tobacco products.